Bio Vitos Pharma AB (publ) reported earnings results for the fourth quarter and full year ended December 31, 2023. For the fourth quarter, the company reported sales was SEK 0.819302 million compared to SEK 1.29 million a year ago. Revenue was SEK 0.819302 million compared to SEK 1.29 million a year ago. Net loss was SEK 5.08 million compared to SEK 2.95 million a year ago.

For the full year, the company reported sales was SEK 3 million compared to SEK 4.74 million a year ago. Revenue was SEK 3 million compared to SEK 4.74 million a year ago. Net loss was SEK 12.87 million compared to SEK 14.9 million a year ago.